These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2147454)

  • 1. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.
    Carlsson M; Svensson A
    Life Sci; 1990; 47(19):1729-36. PubMed ID: 2147454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
    Carlsson M; Svensson A; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):568-73. PubMed ID: 1682816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.
    Carlsson M; Svensson A
    Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
    Carlsson ML; Engberg G; Carlsson A
    J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice.
    Svensson A; Pileblad E; Carlsson M
    J Neural Transm Gen Sect; 1991; 85(2):117-29. PubMed ID: 1930876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 77(1):65-71. PubMed ID: 2545813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
    Svensson A; Carlsson A; Carlsson ML
    J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.
    Fredriksson A; Gentsch C; Archer T
    J Neural Transm Gen Sect; 1994; 97(3):197-209. PubMed ID: 7873129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists.
    French ED; Mura A; Wang T
    Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol behaves as an NMDA antagonist with respect to locomotor stimulation in monoamine-depleted mice.
    Carlsson ML; Engberg G
    J Neural Transm Gen Sect; 1992; 87(2):155-60. PubMed ID: 1558743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal lead exposure and MK-801 sensitivity.
    Cory-Slechta DA
    Neurotoxicology; 1997; 18(1):209-20. PubMed ID: 9216003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.
    Svensson A; Carlsson M; Carlsson A
    J Neural Transm Gen Sect; 1991; 85(1):69-77. PubMed ID: 1867840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.
    Murray JE; Walker AW; Polewan RJ; Bevins RA
    Psychopharmacology (Berl); 2011 Jan; 213(1):131-41. PubMed ID: 20859617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.
    Parada-Turska J; Turski WA
    Neuropharmacology; 1990 Dec; 29(12):1111-6. PubMed ID: 2149871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice.
    Kannari K; Markstein R
    J Neural Transm Gen Sect; 1991; 84(3):211-20. PubMed ID: 1679337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleate.
    Blacker D; Broberger C; Ogren SO; Hökfelt T
    Neuroscience; 1997 Feb; 76(4):1057-67. PubMed ID: 9027866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.
    Klockgether T; Turski L
    Ann Neurol; 1990 Oct; 28(4):539-46. PubMed ID: 2252365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.